Continued growth is supported by rising IBD prevalence and ongoing geographic expansion. Vedolizumab is a biologic medication approved for both intravenous (IV) and subcutaneous (SC) use ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. Entyvio contains the active ingredient vedolizumab. Entyvio is ...